IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 176 filers reported holding IVERIC BIO INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $33,137,484 | -17.2% | 1,362,001 | -27.1% | 0.22% | -32.6% |
| Q4 2022 | $40,007,325 | +19.3% | 1,868,628 | 0.0% | 0.32% | +49.1% |
| Q3 2022 | $33,523,000 | +86.5% | 1,868,628 | 0.0% | 0.21% | +101.9% |
| Q2 2022 | $17,976,000 | -42.8% | 1,868,628 | 0.0% | 0.11% | -25.4% |
| Q1 2022 | $31,449,000 | +1.1% | 1,868,628 | +0.5% | 0.14% | +21.4% |
| Q4 2021 | $31,096,000 | +23.9% | 1,859,817 | +20.3% | 0.12% | +13.6% |
| Q3 2021 | $25,098,000 | – | 1,545,425 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,516,920 | $42,360,000 | 17.00% |
| COMMODORE CAPITAL LP | 2,214,961 | $37,278,000 | 8.33% |
| Ally Bridge Group (NY) LLC | 650,000 | $10,940,000 | 8.11% |
| Vivo Capital, LLC | 6,431,940 | $108,250,000 | 7.45% |
| Samsara BioCapital, LLC | 1,262,551 | $21,249,000 | 5.35% |
| Deep Track Capital, LP | 4,500,000 | $75,735,000 | 4.86% |
| ACUTA CAPITAL PARTNERS, LLC | 539,500 | $9,080,000 | 4.24% |
| Paradigm Biocapital Advisors LP | 910,416 | $15,322,000 | 4.05% |
| Logos Global Management LP | 1,800,000 | $30,294,000 | 3.93% |
| Yiheng Capital Management, L.P. | 5,058,585 | $85,136,000 | 3.89% |